Trials / Completed
CompletedNCT00290901
Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.
A Six Week Double-Blind, Randomized, Multicenter Comparison Study of the Analgesic Effectiveness of Celecoxib 200 mg BID Compared to Tramadol Hydrochloride 50 mg QID in Subjects With Chronic Low Back Pain
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 754 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study investigates if Celebrex is as effective as tramadol hydrochloride (Ultram) for patients with chronic low back pain, when administered over a 6-week period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tramadol Hydrochloride 50mg | |
| DRUG | Celebrex 200mg |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2006-12-01
- First posted
- 2006-02-13
- Last updated
- 2021-03-03
Locations
54 sites across 2 countries: United States, Puerto Rico
Source: ClinicalTrials.gov record NCT00290901. Inclusion in this directory is not an endorsement.